MYC is also a key driver of prostate cancer, and its overexpression starts early in the disease process in HGPIN (56, 61, 62), continues in primary carcinomas, and is also highly expressed in mCRPC (52, 61–63). This evidence concerns the gene MYC and Familial prostate cancer.